Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zonglin Chen

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Plos One|April 19, 2014
Intratumoral CD8⁺ cytotoxic lymphocyte is a favorable prognostic marker in node-negative breast cancerZonglin Chen, Xianyu Chen, Enxiang Zhou, et al.
Biomedical Reports|February 20, 2016
Expression of receptor protein tyrosine phosphatase ζ is a risk factor for triple negative breast cancer relapseFenfen Fu, X I Xiao, Tao Zhang, et al.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery|July 16, 2024
[Application of reverse traction device in preoperative treatment of high-energy tibial plateau fracture]Mingli Chen, Zonglin Chen, Honghan Li, et al.
Biology Direct|July 5, 2020
Long non-coding RNA LINC00426 contributes to doxorubicin resistance by sponging miR-4319 in osteosarcomaLulin Wang, Yi Luo, Yiquan Zheng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 27, 2026
Targeted Degradation of eEF2K by a Structure-Guided PROTAC Strategy for the Treatment of Triple-Negative Breast CancerShijun Cao, Changxin Zhong, Shilong Jiang, et al.
NPJ Precision Oncology|June 18, 2025
Applying a multi-task and multi-instance framework to predict axillary lymph node metastases in breast cancerYizhi Li, Zonglin Chen, Ziyuan Ding, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 5, 2025
Serine/Threonine Kinase 33 as a Novel Target of Bufalin in Treatment of Triple-Negative Breast CancerShilong Jiang, Junyan Liu, Hui Li, et al.
Nature Communications|August 22, 2025
Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alphaShilong Jiang, Keyi Liu, Ting Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2023
Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of AutophagyTing Jiang, Jiaojiao Zhu, Shilong Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 12, 2023
Design and Characterization of a Novel eEF2K Degrader with Potent Therapeutic Efficacy Against Triple-Negative Breast CancerChangxin Zhong, Rongfeng Zhu, Ting Jiang, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Plos One|April 19, 2014
Intratumoral CD8⁺ cytotoxic lymphocyte is a favorable prognostic marker in node-negative breast cancerZonglin Chen, Xianyu Chen, Enxiang Zhou, et al.
Biomedical Reports|February 20, 2016
Expression of receptor protein tyrosine phosphatase ζ is a risk factor for triple negative breast cancer relapseFenfen Fu, X I Xiao, Tao Zhang, et al.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery|July 16, 2024
[Application of reverse traction device in preoperative treatment of high-energy tibial plateau fracture]Mingli Chen, Zonglin Chen, Honghan Li, et al.
Biology Direct|July 5, 2020
Long non-coding RNA LINC00426 contributes to doxorubicin resistance by sponging miR-4319 in osteosarcomaLulin Wang, Yi Luo, Yiquan Zheng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 27, 2026
Targeted Degradation of eEF2K by a Structure-Guided PROTAC Strategy for the Treatment of Triple-Negative Breast CancerShijun Cao, Changxin Zhong, Shilong Jiang, et al.
NPJ Precision Oncology|June 18, 2025
Applying a multi-task and multi-instance framework to predict axillary lymph node metastases in breast cancerYizhi Li, Zonglin Chen, Ziyuan Ding, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 5, 2025
Serine/Threonine Kinase 33 as a Novel Target of Bufalin in Treatment of Triple-Negative Breast CancerShilong Jiang, Junyan Liu, Hui Li, et al.
Nature Communications|August 22, 2025
Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alphaShilong Jiang, Keyi Liu, Ting Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2023
Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of AutophagyTing Jiang, Jiaojiao Zhu, Shilong Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 12, 2023
Design and Characterization of a Novel eEF2K Degrader with Potent Therapeutic Efficacy Against Triple-Negative Breast CancerChangxin Zhong, Rongfeng Zhu, Ting Jiang, et al.
Pageof 3